Jump to Subnavigation

Service Navigation

Biotech Insight

BIOTECH Insight provides information on current developments, trends and topics in the German biotechnology industry. You will find a wide range of information here: There is an overview of the most important economic key figures (Facts & Figures), a selection of current news as well as profiles of relevant start-ups, investors and biotech locations. In addition, there are insights into concrete company strategies via CEO interviews and background information on selected topics in the dossier.

Current Issues

Data and facts at a glance

We have summarised the most important economic indicators of the German biotech industry for you and prepared

Start-ups in the spotlight

The German start-up scene in biotechnology is growing: Here you will find a selection of interesting newcomers.

Biotechnology in the headlines

Stay up to date on the latest news from the biotech industry in Germany. A selection of news at a glance.

 

CEO Interview

Harpreet Singh is co-founder, CEO and member of the Advisory Board of Immatics N.V., a NASDAQ-listed biotechnology company with its headquarters in Germany. Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors, aiming to anable a robust and specific T cell response against these targets. In an interview with BIOTECH Insight, Singh talks about the potential of immunotherapies and the company's current strategy.. 

Dossier

Cancer is the second most common cause of death in Germany. However, the prognosis has improved significantly in recent years. Science has made great strides in the search for new more effective and less invasive treatments. Our new dossier: Oncology - New Approaches in Cancer Therapy provides an overview.

Investors in profile

A growing number of investors is interested in biotechnology. We present relevant investors with their focus and investment volume.


Biotech locations

In many locations in Germany stakeholders are working on biotechnological innovations in science and industry. In this section a selection of relevant regions and their activities is presented.

Stay informed!

We send the BIOTECH Insight Newsletter four times a year. Register now and receive sector-relevant updates regularly by e-mail.

Imprint

The information service BIOTECH Insight is a joint cooperation project of BIOCOM AG and Deutsche Börse AG.

Editorial Lead: BIOCOM AG | Jacobsenweg 61 | 13509 Berlin
Editorial team: Simone Ding, Georg Kääb, Doreen Penso Dolfin

Notice: The content provided in the data and facts section originate from the publication “The German Biotech Sector 2022” of BIOCOM AG. The data is referring to the status of 12/2021 if not otherwise indicated.

The content of BIOTECH Insight will be regularly updated and expanded. The companies/investors profiled have no relationship with Deutsche Börse AG; there are no financial obligations in this regard.


If you have any feedback or questions about BIOTECH Insight, please contact:
Deutsche Börse Cash Market cashmarket@deutsche-boerse.com


© Deutsche Börse Cash Market